(19)
(11) EP 4 539 882 A1

(12)

(43) Date of publication:
23.04.2025 Bulletin 2025/17

(21) Application number: 23823225.0

(22) Date of filing: 15.06.2023
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
C07K 16/24(2006.01)
A61P 35/00(2006.01)
C07K 16/28(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/2803; A61K 2039/55; A61K 2039/507; A61K 2039/54; A61K 2039/545; C07K 16/2818; C07K 16/2887; C07K 2317/56; C07K 2317/52
(86) International application number:
PCT/CN2023/100462
(87) International publication number:
WO 2023/241659 (21.12.2023 Gazette 2023/51)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 16.06.2022 WO PCT/CN2022/099068

(71) Applicant: BeiGene, Ltd.
Grand Cayman KY1-1108 (KY)

(72) Inventor:
  • LI, Xiaotong
    Beijing 102206 (CN)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) METHODS OF TREATING LYMPHOMA USING ANTI-TIGIT ANTIBODIES